Medtech Service Provider HuKui Bio raised US$5.5M for US market expansion

The medtech service provider Hukui Bio (互貴興業) announced that it has raised US$5.5 million in Series C funding, led by Yellowstone Holding AG from Switzerland, totalling US$11.8M funding to date. HuKui Bio will collaborate with venture capital funds in the Bay area, in addition to the biomedical innovation clusters and accelerators in Europe and the US. The New Business Department…

Read more

“Made in China” is no longer attractive due to the U.S.-China trade war, suggesting that Taiwan’s CDMO industry for electronic medical devices is going to be more lucrative

A few days ago, I had visited Hukui Biotechnology Co., Ltd. (Hukui Bio) which was founded by John Hsuan with Michael Kuo, the current CEO. We talked about the latest development in the global electronic medical devices market and the evolution of professional electronic medical devices contract development and manufacturing organization (CDMO) industry since the US-China trade war. In recent…

Read more

We Are Fighting The COVID-19 Threats !

In 2020, the epidemic of COVID-19 has spread in the whole world, and COVID-19 diagnostic kit is definitely a purchasing point from the beginning. Hukui Bio has been authorized bytwo Taiwan nucleic acid diagnostic kit factories to begin providing COVID-19 diagnostic kit for Europe, ASEAN and South America markets, hoping to satisfy their local medical resources.

Read more

Cymmetrik and HUKUI Tech Work Together to Take AcuSense BioMedical Entering China Market

“Blood Leakage Detection System”, developed by AcuSense BioMedical Technology Corp. (AcuSense), is a specific medical device designed for kidney disease patient to reduce the risk of dialysis treatment. Through the cooperation with HUKUI Tech, the subsidy of Hukui Biotechnology Co., Ltd., AcuSense is going to expand its business to China. HUKUI Tech integrates product authorization, registration, production and distribution as…

Read more

HUKUI Bio is Integrating its Network and Arranging Resource for Novel Coronavirus (COVID-19) Diagnostic Kit Supply Chain

In 2020, the epidemic of COVID-19 has spread in the whole world, and COVID-19 diagnostic kit is definitely a purchasing point from the beginning. HUKUI Bio has been authorized by two Taiwan nucleic acid diagnostic kit factories to begin providing COVID-19 diagnostic kit for Europe, ASEAN and South America markets, hoping to satisfy their local medical resources.

Read more

Notes for Registration in China

What are the central authorities in charge of medical devices in various countries? United States  Food and Drug Administration (FDA) Attached to United States Department of Health, Education, and Welfare, is in charge of the administration of drugs, food, biological products, cosmetics, veterinary drugs, medical devices and diagnostic supplies throughout the country. Taiwan  Taiwan Food…

Read more

Clinical Guidelines in China

Are clinical trials necessary for medical devices to enter China? According to the 2018 announcement on the latest “Catalogue of medical devices exempted from clinical trials” (No. 94, 2018) and “Catalogue of IVD reagents exempted from clinical trials”, when the product description conforms to the medical devices or IVD reagents of the specification on the…

Read more

Policy Guidelines in China

What are the norms for setting up a medical device factory in China? Good Manufacturing Practice for Medical Devices and YY0287-2017-Medical Devices-Quality Management Systems-Requirements for regulatory purposes / ISO 13485:2016 need to be followed. What is the current situation of centralized procurement of medical consumables? In March 2018, China changed the National Health and Family…

Read more

Innovative Medical Devices in China

What are innovative medical devices? The core technology of the product has Chinese patent right for invention, or the application for invention patent has been reported to the Patent Administration Department under the State Council of China. The main working principle or action mechanism of the product is the first in China, and the product…

Read more

The Hukui Biotechnology Corporation in Collaboration with the Zhongguancun Medical Engineering Transformation (Chongqing) Center to Obtain a Category III License from the CFDA for Medical Equipment

The Hukui Biotechnology (Chongqing) Corporation, the subsidiary of Hukui Biotechnology Corporation, signed the Cooperation Framework Agreement with the Zhongguancun Medical Engineering Transformation (Chongqing) Center to promote the development of the biotechnology industry. The goal of the Agreement is to create a biotech incubator platform that promotes the smart medical industry focusing on the development of medicine, top-of-the-range medical equipment, testing…

Read more
 Compal Group cooperate with Hukui Biotechnology Corporation to Enter Medical Market in China

Compal Group cooperate with Hukui Biotechnology Corporation to Enter Medical Market in China

Taipei, Taiwan, June 13, 2017 General Life Biotechnology Co., Ltd., an affiliate of Compal Group (TWSE:2324), has signed a contract with Hukui Biotechnology Corporation. General Life Biotechnology Co., Ltd. will provide the key components and technical support, and Hukui Technology, the Chongqing-based subsidiary of Hukui Biotechnology Corporation is then responsible to apply for the license…

Read more

First BMS Partner

The Taiwan Carbon Nanotube Technology Corporation (TCNT) announced Wednesday (2017/03/29) that it has inked a BMS(Biotech Manufacturing Services) contract and marketing memorandum of understanding (MOU) with HuKui.

Read more

UMC’s John Hsuan eyes biotech market across strait

By John Liu, The China Post  August 16, 2016, 12:30 am TWN The China PostTaiwan’s high-tech guru John Hsuan (宣明智) aims for significant growth in mainland China’s market in order to make the biotech industry the next pride of Taiwan. The honorary vice chairman of the United Microelectronics Corp (UMC, 聯電), one of Taiwan’s leading high-tech companies, has high expectations…

Read more